CMS vs CTKB · P/E 20, $22.42B cap vs rev $200.5M
CMS Energy Corporation (CMS) versus Cytek Biosciences Inc (CTKB) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
CMS does not have a complete income-statement cache yet.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. CTKB currently screens at market cap $421.8M.
Not investment advice. Open the CMS and CTKB stock pages for the full models.
Not investment advice.